Skip to main content
Have a personal or library account? Click to login
Increased late urinary toxicity with whole pelvic radiotherapy after prostatectomy Cover

Increased late urinary toxicity with whole pelvic radiotherapy after prostatectomy

Radiology and Oncology
Volume 43 (2009): Issue 2 (June 2009)
By:   
Open Access
|Jun 2009
References

References

  1. Thompson IM, Tangen CM, Paradelo J, Lucia S, Miller G, Troyer D, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer.2006; 296: 2329-35.
    Open DOISearch in Google Scholar
  2. Bolla M, van Poppel H, Colette L, van Cangh P, Vekemans K, Da Pozzo L, et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911).2005; 366: 52-8.
    Open DOISearch in Google Scholar
  3. Wiegel T, Bottke D, Willich H, Piechota H, Souchon R, Stoeckle M, et al. Phase III results of adjuvant radiotherapy (RT) versus »wait and see« (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP)(ARO 96-02/AUO AP 09/95). [Abstract].2005; 23(Part 1 Suppl): 381S.
    Open DOISearch in Google Scholar
  4. Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, et al. Predicting the outcomes of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.2007; 25: 2035-41.
    Open DOISearch in Google Scholar
  5. Jani AB, Sokoloff M, Shalhav A, Stadler W. Androgen ablation adjuvant to postprostatectomy radiotherapy: complication-adjusted number needed to treat analysis.2004; 64: 976-81.
    Open DOISearch in Google Scholar
  6. Zelefsky MJ, Aschkenasy E, Kelesen S, Leibel SA. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy.1997; 39: 327-33.
    Open DOISearch in Google Scholar
  7. Cox JD, Gallagher MJ, Hammond EH, Kaplan RS, Schellhammer PF. Consensus statement on radiation therapy of prostate cancer: guidlines for prostate re-biopsy after radiation and for radiation therapy with rising prostate specific antigen levels after radical prostatectomy. American Society for Terapeutic Radiology and Oncology consensus panel.1999; 17: 1155-63.
    Search in Google Scholar
  8. Poortmans P, Bossi A, Vandeputte K, Bosset M, Miralbell R, Maingon P, et al. Guidlines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.2007; 84: 121-7.
    Open DOISearch in Google Scholar
  9. Spiotto MT, Hancock SL, King CR. Radiotherapy after prostatectomy: improved biochemical relaps-free survival with whole pelvic compared with prostate bed only for high-risk patients.2007; 69: 54-61.
    Open DOISearch in Google Scholar
  10. Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial.2000; 48: 635-42.
    Open DOISearch in Google Scholar
  11. Parmar MKB, Machin D.Chichester: John Wiley&Sons; 1995.
    Search in Google Scholar
  12. Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton C, Michalski J, et al. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy.2007; 68: 1417-23.
    Open DOISearch in Google Scholar
  13. Valicenti RK, Gomella LG, Ismail M, Mulholland SG, Petersen RO, Corn BW. Effects of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer.1998; 42: 501-6.
    Open DOISearch in Google Scholar
  14. Jereczek-Fossa BA, Zerini D, Vavassori A. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.2008 74: 115-25.
    Open DOISearch in Google Scholar
  15. Pearse M, Choo R, Danjoux C, Gardner S, Morton G, Szumacher E, et al. Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relaps or local recurrence after radical prostatectomy.2008; 72: 792-8.
    Open DOISearch in Google Scholar
  16. Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Eble MJ. Low-grade toxicity after conformal radiation therapy for prostate cancer - impact of bladder volume.2006; 64: 835-41.
    Open DOISearch in Google Scholar
  17. Harsolia A, Vargas C, Yan D, Brabbins D, Lockman D, Liang J, et al. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.2007; 69: 1100-9.
    Open DOISearch in Google Scholar
  18. Portelance L, Chao KSC, Grigsby PW, Benet H, Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum and bladder dose in patients with cervical cancer receiving pelvic and para-aortic radiation.2001; 51: 261-6.
    Open DOISearch in Google Scholar
  19. Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies.2000; 48: 1613-21.
    Open DOISearch in Google Scholar
  20. Heidenreich A, Ohlmann CH, Polyakov S. Anatomical extent of pelvic lymphadenectomy in bladder and prostate cancer.2005; 4: 15-24.
    Open DOISearch in Google Scholar
  21. Roach M 3rd, Marquez C, Yuo HS. Predicting the risk of lymph node involvement using the pretreatment prostatic specific antigen and Gleason score in men with clinically localized prostate cancer.1994; 28: 33-7.
    Open DOISearch in Google Scholar
  22. Shih HA, Harisinghani M, Zietman AL, Wolfgang JA, Saksena M, Weissleder R. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anathomy.2005; 63: 1262-9.
    Open DOISearch in Google Scholar
  23. Corn BW, Winter K, Pilepich MV. Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-13.1999; 54: 495-502.
    Open DOISearch in Google Scholar
  24. Taussky D, Bae K, Bahary JP. Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413.2008; 72: 1125-9.
    Open DOISearch in Google Scholar
  25. Cox JD, Stetz JA, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC).1995; 31: 1341-6.
    Open DOISearch in Google Scholar
  26. Botros M, Quevedo JF, Miller RC. Angiosarcoma of the liver after multimodality therapy for gallbladder carcinoma.2009; 43: 126-31.
    Open DOISearch in Google Scholar
  27. Velenik V, Oblak I, Anderluh F. Quality of life in patients after combined modality treatment of rectal cancer: Report of a prospective phase II study.2008: 42: 207-14.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-009-0014-z | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 88 - 96
Published on: Jun 8, 2009
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
prostate cancer,
postoperative radiotherapy,
whole pelvic radiotherapy,
late toxicity
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2009 Borut Kragelj, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 43 (2009): Issue 2 (June 2009)
Previous article
Next article